Author

Shatha AbuHammad

Harvard UniversityORCID 0000-0001-9138-270XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:genetic perturbation / CRISPR· 1 Approach:statistical model· 1

Frequent Co-Authors

Jiao LiiD· 2 shared Srinivas R. Viswanathan· 2 shared Ananthan SadagopaniD· 1 shared Bingchen LiiD· 1 shared Craig A. Strathdee· 1 shared David Y. Takeda· 1 shared Eddy SaadiD· 1 shared Ji-Heui SeoiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jiao LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 11, 2025

Dual Inhibition of CDK4/6 and mTORC1 Establishes a Preclinical Strategy for Translocation Renal Cell Carcinoma

Shikha Gupta, Prateek Khanna, Eddy Saad…·Srinivas R. Viswanathan

This study identifies CDK4/6 and mTORC1 pathway activation in tRCC and shows that their dual inhibition synergistically suppresses tRCC cell growth in vitro and xenografts in vivo.

DOI 10.1101/2025.07.11.663903

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCell ReportsPeer-reviewedFeb 1, 2022

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer

Stephen Tang, Nebiyou Y. Metaferia, Marina F. Nogueira…·Srinivas R. Viswanathan

This study identifies PRMT1 as a critical regulator of AR signaling in prostate cancer through genome-scale CRISPR screening and shows its potential as a therapeutic target.

DOI 10.1016/j.celrep.2022.110417

humangenetic perturbation / CRISPR

𝕏 PostBluesky